These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 6407735)

  • 1. [Serum complements and circulating immune complex in patients with systemic lupus erythematosus].
    Tang HY
    Zhonghua Yi Xue Za Zhi; 1983 Feb; 63(2):83-6. PubMed ID: 6407735
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serial studies of serum immune complexes and complements in patients with glomerulonephritis].
    Nakayama S; Koide H; Ohno J
    Nihon Jinzo Gakkai Shi; 1984 Feb; 26(2):163-9. PubMed ID: 6611432
    [No Abstract]   [Full Text] [Related]  

  • 3. [Detection of circulating immune complexes in systemic lupus erythematosus by the method of conglutinin and monoclonal rheumatoid factor].
    de Oliveira RM; Marchiori PE; Viana Vdos S; Bueno C; dos Reis M; Quevedo ME; Cossermelli W
    Rev Hosp Clin Fac Med Sao Paulo; 1985; 40(1):6-9. PubMed ID: 4059787
    [No Abstract]   [Full Text] [Related]  

  • 4. [Detection of circulating immune complexes in patients with lupus erythematosus, viral hepatitis and rheumatoid arthritis using radioactive marked C1q].
    Nydegger U; Lambert PH; Miescher PA
    Verh Dtsch Ges Inn Med; 1974; 80():1575-7. PubMed ID: 4217986
    [No Abstract]   [Full Text] [Related]  

  • 5. [Natural cytotoxicity in systemic lupus erythematosus patients].
    Aleksandrova EN; Nasonov EL; Bykhovskaia SIu; Ivanova MM; Solov'ev SK
    Ter Arkh; 1984; 56(5):29-32. PubMed ID: 6463883
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of treatment with enkorton and cytostatics on selected immunologic indicators in patients with systemic lupus erythematosus].
    Małdykowa H; Chwalińska-Sadowska H; Grabowska A; Dratwianka B; Abgarowicz-Miłkowska T; Jedryka-Góral A; Swierczyńska Z; Rdułtowska H; Luft S; Rogozińska E
    Reumatologia; 1982; 20(1-2):7-14. PubMed ID: 7163667
    [No Abstract]   [Full Text] [Related]  

  • 7. [The significance of immuno-biologic parameters during and in the prognosis of patients with systemic lupus erythematosus].
    Ljaljević M; Ljaljević J; Zlatković Lj; Latković J
    Glas Srp Akad Nauka Med; 1982; (35):111-20. PubMed ID: 7182242
    [No Abstract]   [Full Text] [Related]  

  • 8. Circulating immune complexes and the complements system in lupus nephropathy.
    Serban MG
    Rom J Intern Med; 1992; 30(2):119-25. PubMed ID: 1496264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical characteristics of patients with nuclear antiribonucleoprotein antibodies. Evidence of circulating immunocomplexes in mixed connective tissue disease].
    Rodríguez-Valverde V; Orte Martínez J; Sampedro Alvarez J; Peña Sagredo JL; Sánchez Andrada S
    Med Clin (Barc); 1982 Jun; 79(1):9-15. PubMed ID: 7121111
    [No Abstract]   [Full Text] [Related]  

  • 10. [Circulating immune complexes in the serum of patients with SLE].
    Sykulev IuK; Solov'ev SK; Sazhina EG; Lenchevskaia EV; Ostreĭko KK
    Klin Med (Mosk); 1988 Jul; 66(7):46-9. PubMed ID: 3184826
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of plasmapheresis in active systemic lupus erythematosus.
    Kater L; Derksen RH; Houwert DA; Hené RJ; Struyvenberg A; Gmelig Meyling FH; Verroust P
    Neth J Med; 1981; 24(6):209-16. PubMed ID: 7322246
    [No Abstract]   [Full Text] [Related]  

  • 12. Lupus erythematosus panniculitis (profundus).
    Tuffanelli DL
    Arch Dermatol; 1971 Mar; 103(3):231-42. PubMed ID: 4100949
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of circulating immune complexes in lupus nephritis by solid phase C1q and conglutinin binding assays.
    Yoshida H; Muso E; Inoue S; Furukawa F; Sekita K; Kawai C; Hamashima Y
    Nihon Jinzo Gakkai Shi; 1984 Mar; 26(3):293-300. PubMed ID: 6611433
    [No Abstract]   [Full Text] [Related]  

  • 14. [Determination of circulating immune complexes in the serum of patients with autoimmune diseases in the active and inactive stage].
    Török K; Gergely P; Petrányi G
    Orv Hetil; 1979 May; 120(18):1071-3. PubMed ID: 440727
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunologic studies on systemic lupus erythematosus.
    Shi SY; Kang KF; Weng MW; Tian RM; Hou AQ
    Chin Med J (Engl); 1985 May; 98(5):336-42. PubMed ID: 3926405
    [No Abstract]   [Full Text] [Related]  

  • 16. [Characteristics of the immune complex process in patients with systemic lupus erythematosus with predominant kidney involvement].
    Nasonov EL; Solov'ev SK; Sura VV; Ivanova MM; Poverennyĭ AM
    Ter Arkh; 1986; 58(8):57-62. PubMed ID: 2945280
    [No Abstract]   [Full Text] [Related]  

  • 17. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
    Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
    Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunological and biochemical characteristics of circulating immune complexes in rheumatoid arthritis and systemic lupus erythematosus].
    Venalis AI; Matulis AA; Mishkinite GA; Stankaĭtene DI
    Ter Arkh; 1983; 55(7):24-8. PubMed ID: 6194570
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical features of systemic lupus erythematosus patients with antihistone antibodies.
    Fritzler M; Ryan P; Kinsella TD
    J Rheumatol; 1982; 9(1):46-51. PubMed ID: 7086779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Deposited and circulating immune complexes in systemic lupus erythematosus].
    Cebecauer L; Zitnan D; Rovenský J
    Fysiatr Revmatol Vestn; 1971 Apr; 49(2):69-75. PubMed ID: 4102368
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.